Verona Pharma
VRNA
$13.00
Share price
-2.69%
Change (1 day)
-33.09%
Change (1 year)
Categories
Verona Pharma (VRNA) - P/B ratio
P/B ratio as of May 2024 : 4.35
According to Verona Pharma's latest financial reports the company has a price-to-book ratio of 4.35.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Verona Pharma - P/B ratio (from 2020 to 2020)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 6.38 | -25.65% |
| 2022-12-31 | 8.57 | 214.68% |
| 2021-12-31 | 2.72 | 24.24% |
| 2020-12-31 | 2.19 | 62.36% |
| 2019-12-31 | 1.35 | 8.6% |
| 2018-12-31 | 1.24 | 16.46% |
| 2017-12-31 | 1.07 | 44.67% |
| 2016-12-31 | 0.7383 | -79.53% |
| 2015-12-31 | 3.61 | 483.88% |
| 2014-12-31 | 0.6176 | |
| 2013-12-31 | N/A | -100% |
| 2012-12-31 | 2.99 | |
| 2011-12-31 | N/A | |
| 2010-12-31 | N/A | |
| 2009-12-31 | N/A | -100% |
| 2008-12-31 | 0.9619 | |
| 2007-12-31 | N/A | |
| 2006-12-31 | N/A | |
| 2005-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -6.34 | -246.00% | Bahamas |
 NRC Health
NRC | 15.5 | 257.37% | 🇺🇸 USA |